Advertisements



Fulcrum Therapeutics Proposes Terms For IPO

Fulcrum Therapeutics Proposes Terms For IPO.....»»

Category: topSource: seekingalphaJul 11th, 2019

IPO Update: Frequency Therapeutics Proposes Terms

IPO Update: Frequency Therapeutics Proposes Terms.....»»

Category: topSource: seekingalphaSep 25th, 2019

IPO Update: Aprea Therapeutics Proposes IPO Terms

IPO Update: Aprea Therapeutics Proposes IPO Terms.....»»

Category: topSource: seekingalphaSep 24th, 2019

IPO Update: Monopar Therapeutics Proposes Terms For IPO

IPO Update: Monopar Therapeutics Proposes Terms For IPO.....»»

Category: topSource: seekingalphaSep 11th, 2019

Prevail Therapeutics Proposes IPO Terms

Prevail Therapeutics Proposes IPO Terms.....»»

Category: topSource: seekingalphaJun 13th, 2019

IPO Update: Trevi Therapeutics Proposes IPO Terms

IPO Update: Trevi Therapeutics Proposes IPO Terms.....»»

Category: topSource: seekingalphaApr 22nd, 2019

Rubius Therapeutics Proposes Terms For $200 Million IPO

Rubius Therapeutics Proposes Terms For $200 Million IPO.....»»

Category: topSource: seekingalphaJul 9th, 2018

Fulcrum Therapeutics reports Q3 EPS (97c), consensus ($2.98)

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall8 hr. 59 min. ago

IPO Update: Ecmoho Proposes U.S. IPO Terms

IPO Update: Ecmoho Proposes U.S. IPO Terms.....»»

Category: topSource: seekingalphaNov 5th, 2019

IPO Update: 36Kr Holdings Proposes Terms For U.S. IPO

IPO Update: 36Kr Holdings Proposes Terms For U.S. IPO.....»»

Category: topSource: seekingalphaNov 3rd, 2019

IPO Update: Centogene Proposes U.S. IPO Terms

IPO Update: Centogene Proposes U.S. IPO Terms.....»»

Category: topSource: seekingalphaOct 31st, 2019

Galera Therapeutics to offer 5 million shares in IPO priced at $14 to $16 each

Galera Therapeutics Inc. set terms for its planned initial pub.....»»

Category: topSource: marketwatchOct 28th, 2019

IPO Update: GFL Environmental Proposes U.S. IPO Terms

IPO Update: GFL Environmental Proposes U.S. IPO Terms.....»»

Category: topSource: seekingalphaOct 23rd, 2019

Fulcrum Therapeutics management to meet with SVB Leerink

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 17th, 2019

IPO Update: Phathom Pharmaceuticals Proposes IPO Terms

IPO Update: Phathom Pharmaceuticals Proposes IPO Terms.....»»

Category: topSource: seekingalphaOct 15th, 2019

Fulcrum Therapeutics announces results of Phase 1 clinical trial of losmapimod

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 4th, 2019

Fulcrum Therapeutics initiated with a Buy at H.C. Wainwright

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 3rd, 2019

IPO Update: Karat Packaging Proposes IPO Terms

IPO Update: Karat Packaging Proposes IPO Terms.....»»

Category: topSource: seekingalphaOct 2nd, 2019

IPO Update: Vir Biotechnology Proposes IPO Terms

IPO Update: Vir Biotechnology Proposes IPO Terms.....»»

Category: topSource: seekingalphaOct 1st, 2019

IPO Update: HBT Financial Proposes IPO Terms

IPO Update: HBT Financial Proposes IPO Terms.....»»

Category: topSource: seekingalphaOct 1st, 2019

Fulcrum Therapeutics expects to file IND for FTX-6058 in mid-2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 1st, 2019